324 related articles for article (PubMed ID: 18166106)
1. Correlation between salivary and serum markers of bone turnover in osteopenic rats.
Pellegrini GG; Gonzales CM; Somoza JC; Friedman SM; Zeni SN
J Periodontol; 2008 Jan; 79(1):158-65. PubMed ID: 18166106
[TBL] [Abstract][Full Text] [Related]
2. [Bone remodeling markers in saliva as compared to serum in rats].
Pellegrini G; Gonzáles Chaves M; Somoza J; Friedman S; Zeni SN
Medicina (B Aires); 2006; 66(3):245-8. PubMed ID: 16871913
[TBL] [Abstract][Full Text] [Related]
3. Changes in bone volume and bone resorption by olpadronate treatment in an experimental model of uremic bone disease.
Tomat A; Gamba CA; Mandalunis P; De Grandi MC; Somoza J; Friedman S; Zeni S
J Musculoskelet Neuronal Interact; 2005 Jun; 5(2):174-81. PubMed ID: 15951635
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats.
Mastaglia SR; Pellegrini GG; Mandalunis PM; Gonzales Chaves MM; Friedman SM; Zeni SN
Bone; 2006 Oct; 39(4):837-44. PubMed ID: 16765665
[TBL] [Abstract][Full Text] [Related]
5. Low-level lifetime exposure to cadmium decreases skeletal mineralization and enhances bone loss in aged rats.
Brzóska MM; Moniuszko-Jakoniuk J
Bone; 2004 Nov; 35(5):1180-91. PubMed ID: 15542044
[TBL] [Abstract][Full Text] [Related]
6. Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate.
Burshell AL; Möricke R; Correa-Rotter R; Chen P; Warner MR; Dalsky GP; Taylor KA; Krege JH
Bone; 2010 Apr; 46(4):935-9. PubMed ID: 20060081
[TBL] [Abstract][Full Text] [Related]
7. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat.
Cho DC; Kim KT; Jeon Y; Sung JK
Acta Neurochir (Wien); 2012 Dec; 154(12):2215-23. PubMed ID: 23053289
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological effects of tiludronate in horses after long-term immobilization.
Delguste C; Amory H; Doucet M; Piccot-Crézollet C; Thibaud D; Garnero P; Detilleux J; Lepage OM
Bone; 2007 Sep; 41(3):414-21. PubMed ID: 17604709
[TBL] [Abstract][Full Text] [Related]
9. [Effects of Dioscorea septemloba on bone metabolism in ovariectomized rats].
Xing GS; Lou JS; Wang ZB; Yu SL; Wang Y; Sheng L
Zhongguo Zhong Yao Za Zhi; 2007 Sep; 32(18):1909-13. PubMed ID: 18051905
[TBL] [Abstract][Full Text] [Related]
10. Primary prevention of glucocorticoid-induced osteoporosis with intravenous pamidronate and calcium: a prospective controlled 1-year study comparing a single infusion, an infusion given once every 3 months, and calcium alone.
Boutsen Y; Jamart J; Esselinckx W; Devogelaer JP
J Bone Miner Res; 2001 Jan; 16(1):104-12. PubMed ID: 11149473
[TBL] [Abstract][Full Text] [Related]
11. Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial.
Grey A; Bolland MJ; Horne A; Wattie D; House M; Gamble G; Reid IR
Bone; 2012 Jun; 50(6):1389-93. PubMed ID: 22465268
[TBL] [Abstract][Full Text] [Related]
12. [Effects of teriparatide and alendronate on bone mineral density of osteoporotic rats].
Li M; Jiao J; Meng XW; Xing XP; Xia WB; Zhou XY; Liu HC; Jiang Y; Wang O; Hu YY; Zhan ZW
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):335-8. PubMed ID: 15854512
[TBL] [Abstract][Full Text] [Related]
13. Long-term effects of withdrawal of bisphosphonate incadronate disodium (YM175) on bone mineral density, mass, structure, and turnover in the lumbar vertebrae of ovariectomized rats.
Tamura Y; Miyakoshi N; Itoi E; Abe T; Kudo T; Tsuchida T; Kasukawa Y; Sato K
J Bone Miner Res; 2001 Mar; 16(3):541-9. PubMed ID: 11277272
[TBL] [Abstract][Full Text] [Related]
14. Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate.
McClung M; Recker R; Miller P; Fiske D; Minkoff J; Kriegman A; Zhou W; Adera M; Davis J
Bone; 2007 Jul; 41(1):122-8. PubMed ID: 17468062
[TBL] [Abstract][Full Text] [Related]
15. Correlations of serum prolidase activity between bone turnover markers and mineral density in postmenopausal osteoporosis.
Verit FF; Geyikli I; Yazgan P; Celik A
Arch Gynecol Obstet; 2006 Jun; 274(3):133-7. PubMed ID: 16532321
[TBL] [Abstract][Full Text] [Related]
16. Jumping exercise preserves bone mineral density and mechanical properties in osteopenic ovariectomized rats even following established osteopenia.
Okubo R; Sanada LS; Castania VA; Louzada MJ; de Paula FJ; Maffulli N; Shimano AC
Osteoporos Int; 2017 Apr; 28(4):1461-1471. PubMed ID: 28124728
[TBL] [Abstract][Full Text] [Related]
17. Effects of cod bone gelatin on bone metabolism and bone microarchitecture in ovariectomized rats.
Han X; Xu Y; Wang J; Pei X; Yang R; Li N; Li Y
Bone; 2009 May; 44(5):942-7. PubMed ID: 19124090
[TBL] [Abstract][Full Text] [Related]
18. Silicon supplementation improves the bone mineral density of calcium-deficient ovariectomized rats by reducing bone resorption.
Kim MH; Bae YJ; Choi MK; Chung YS
Biol Trace Elem Res; 2009 Jun; 128(3):239-47. PubMed ID: 19034393
[TBL] [Abstract][Full Text] [Related]
19. Long-term minodronic acid (ONO-5920/YM529) treatment suppresses increased bone turnover, plus prevents reduction in bone mass and bone strength in ovariectomized rats with established osteopenia.
Tanaka M; Mori H; Kayasuga R; Ochi Y; Kawada N; Yamada H; Kishikawa K
Bone; 2008 Nov; 43(5):894-900. PubMed ID: 18687415
[TBL] [Abstract][Full Text] [Related]
20. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
Trento LK; Pietropolli A; Ticconi C; Gravotta E; De Martino MU; Fabbri A; Piccione E
J Obstet Gynaecol Res; 2009 Feb; 35(1):152-9. PubMed ID: 19215563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]